BLASTP 2.2.26 [Sep-21-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= 048703
         (361 letters)

Database: pdbaa 
           62,578 sequences; 14,973,337 total letters

Searching..................................................done



>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
          Length = 261

 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 72/143 (50%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 7   YQEDIHTYLREMEVKCKPKVGYMKR-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 65

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TYS+++VL+ME 
Sbjct: 66  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEH 125

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 126 LVLKVLAFDLAAPTVNQFLTQYF 148


>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
 pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
          Length = 257

 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 72/143 (50%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 4   YQEDIHTYLREMEVKCKPKVGYMKR-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TYS+++VL+ME 
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEH 122

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 123 LVLKVLAFDLAAPTVNQFLTQYF 145


>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
 pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
          Length = 258

 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 72/143 (50%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 4   YQEDIHTYLREMEVKCKPKVGYMKR-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TYS+++VL+ME 
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYSKKQVLRMEH 122

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 123 LVLKVLAFDLAAPTVNQFLTQYF 145


>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
 pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
          Length = 264

 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLAFDLAAPTINQFLTQYF 149


>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
 pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
          Length = 269

 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLAFDLAAPTINQFLTQYF 149


>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
 pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
          Length = 268

 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLAFDLAAPTINQFLTQYF 149


>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
          Length = 262

 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLAFDLAAPTINQFLTQYF 149


>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLTFDLAAPTVNQFLTQYF 149


>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
 pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
          Length = 262

 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLAFDLAAPTINQFLTQYF 149


>pdb|1VIN|A Chain A, Bovine Cyclin A3
          Length = 268

 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLAFDLAAPTINQFLTQYF 149


>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLTFDLAAPTVNQFLTQYF 149


>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
 pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
          Length = 265

 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 11  YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 69

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 70  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 129

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 130 LVLKVLTFDLAAPTVNQFLTQYF 152


>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
 pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 8   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 126

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 127 LVLKVLTFDLAAPTVNQFLTQYF 149


>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 261

 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 7   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 65

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 66  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 125

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 126 LVLKVLTFDLAAPTVNQFLTQYF 148


>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
 pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 260

 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 6   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 64

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 65  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 124

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 125 LVLKVLTFDLAAPTVNQFLTQYF 147


>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
 pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
          Length = 256

 Score =  134 bits (336), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 2   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 60

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 61  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 120

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 121 LVLKVLTFDLAAPTVNQFLTQYF 143


>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
          Length = 259

 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 5   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 63

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 64  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 123

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 124 LVLKVLTFDLAAPTVNQFLTQYF 146


>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
 pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
          Length = 258

 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 4   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 122

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 123 LVLKVLTFDLAAPTVNQFLTQYF 145


>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
 pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
          Length = 261

 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 4   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 122

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 123 LVLKVLTFDLAAPTVNQFLTQYF 145


>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
          Length = 260

 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 71/143 (49%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 219 YAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTV 278
           Y  DI++ L+  E+  +P   +M+  Q DIT +MR ILVDWLVEV EEYKL  +TL++ V
Sbjct: 6   YHEDIHTYLREMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 64

Query: 279 YLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMES 338
             ID FL    + R +LQL+G   ML+ASK+EEI  P   EF +ITD+TY++++VL+ME 
Sbjct: 65  NYIDRFLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRMEH 124

Query: 339 QVLKCLGFQLFVPTTKTFL-RYF 360
            VLK L F L  PT   FL +YF
Sbjct: 125 LVLKVLTFDLAAPTVNQFLTQYF 147


>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
 pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
          Length = 269

 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 61/144 (42%), Positives = 95/144 (65%), Gaps = 2/144 (1%)

Query: 215 LCSLYAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTL 274
           L S Y  DIY+ L+  E  +   P ++  + R++T  MR IL+DWLV+V  +++L+ +T+
Sbjct: 2   LSSEYVKDIYAYLRQLEAAQAVRPKYL--LGREVTGNMRAILIDWLVQVQMKFRLLQETM 59

Query: 275 YMTVYLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVL 334
           YMTV +ID F+  N + ++ LQL+G+T M IASKYEE+  P   +F F+TDNTY++ ++ 
Sbjct: 60  YMTVSIIDRFMQNNSVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIR 119

Query: 335 KMESQVLKCLGFQLFVPTTKTFLR 358
           +ME ++L+ L F L  P    FLR
Sbjct: 120 QMEMKILRALNFGLGRPLPLHFLR 143


>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
          Length = 260

 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 61/143 (42%), Positives = 95/143 (66%), Gaps = 2/143 (1%)

Query: 216 CSLYAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLY 275
           CS Y  DIY+ L+  E  +   P ++  + R++T  MR IL+DWLV+V  +++L+ +T+Y
Sbjct: 1   CSEYVKDIYAYLRQLEEEQAVRPKYL--LGREVTGNMRAILIDWLVQVQMKFRLLQETMY 58

Query: 276 MTVYLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLK 335
           MTV +ID F+  N + ++ LQL+G+T M IASKYEE+  P   +F F+TDNTY++ ++ +
Sbjct: 59  MTVSIIDRFMQNNCVPKKMLQLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQ 118

Query: 336 MESQVLKCLGFQLFVPTTKTFLR 358
           ME ++L+ L F L  P    FLR
Sbjct: 119 MEMKILRALNFGLGRPLPLHFLR 141


>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
          Length = 283

 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/124 (37%), Positives = 74/124 (59%), Gaps = 4/124 (3%)

Query: 239 NFMETVQRDITQA-MRGILVDWLVEVSEEYKLVPDTLYMTVYLIDWFLC-QNYIERQRLQ 296
           +F+E  Q  + Q  MR IL+DWL+EV E YKL  +T Y+     D ++  Q  + +  LQ
Sbjct: 37  HFLE--QHPLLQPKMRAILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQ 94

Query: 297 LLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLKCLGFQLFVPTTKTF 356
           L+GI+ + IA+K EEI  P+  +F ++TD   S +E+L ME  ++K L ++L   T  ++
Sbjct: 95  LIGISSLFIAAKLEEIYPPKLHQFAYVTDGACSGDEILTMELMIMKALKWRLSPLTIVSW 154

Query: 357 LRYF 360
           L  +
Sbjct: 155 LNVY 158


>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 257

 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 72/125 (57%)

Query: 236 PFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTVYLIDWFLCQNYIERQRL 295
           P  ++ + VQ+++  +MR I+  W++EV EE K   +   + +  +D FL    +++ RL
Sbjct: 26  PSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRL 85

Query: 296 QLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLKCLGFQLFVPTTKT 355
           QLLG TCM +ASK +E     AE+ C  TDN+   EE+L+ME  ++  L + L   T   
Sbjct: 86  QLLGATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHD 145

Query: 356 FLRYF 360
           F+ +F
Sbjct: 146 FIEHF 150


>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 271

 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 72/125 (57%)

Query: 236 PFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTVYLIDWFLCQNYIERQRL 295
           P  ++ + VQ+++  +MR I+  W++EV EE K   +   + +  +D FL    +++ RL
Sbjct: 40  PSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRL 99

Query: 296 QLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLKCLGFQLFVPTTKT 355
           QLLG TCM +ASK +E     AE+ C  TDN+   EE+L+ME  ++  L + L   T   
Sbjct: 100 QLLGATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHD 159

Query: 356 FLRYF 360
           F+ +F
Sbjct: 160 FIEHF 164


>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
 pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
          Length = 306

 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 61/125 (48%)

Query: 236 PFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTVYLIDWFLCQNYIERQRL 295
           P  ++ + VQR+I   MR +L  W++EV EE +   +   + +  +D +L      + +L
Sbjct: 54  PRASYFQCVQREIKPHMRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQL 113

Query: 296 QLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLKCLGFQLFVPTTKT 355
           QLLG  CML+ASK  E      E+ C  TD+  S  ++   E  VL  L + L       
Sbjct: 114 QLLGAVCMLLASKLRETTPLTIEKLCIYTDHAVSPRQLRDWEVLVLGKLKWDLAAVIAHD 173

Query: 356 FLRYF 360
           FL + 
Sbjct: 174 FLAFI 178


>pdb|1G3N|C Chain C, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
 pdb|1G3N|G Chain G, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
          Length = 257

 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 3/136 (2%)

Query: 212 DPQLCSLYAADIYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVP 271
           DP LC      I+ N+   E       +   T Q+ +T  MR +L  W+  V +EY L P
Sbjct: 13  DPTLCE---DRIFYNILEIEPRFLTSDSVFGTFQQSLTSHMRKLLGTWMFSVCQEYNLEP 69

Query: 272 DTLYMTVYLIDWFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSRE 331
           + + + + L+D  L    + ++  Q  G  C+L+ASK   +        C+   +++SR+
Sbjct: 70  NVVALALNLLDRLLLIKQVSKEHFQKTGSACLLVASKLRSLTPISTSSLCYAAADSFSRQ 129

Query: 332 EVLKMESQVLKCLGFQ 347
           E++  E ++L+ L ++
Sbjct: 130 ELIDQEKELLEKLAWR 145


>pdb|1JOW|A Chain A, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
           Cyclin
 pdb|1XO2|A Chain A, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
           Complex With A Flavonol Inhibitor, Fisetin
 pdb|2EUF|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
           Inhibitor Pd0332991
 pdb|2F2C|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
           Aminopurvalanol
          Length = 254

 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 66/124 (53%), Gaps = 1/124 (0%)

Query: 223 IYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTVYLID 282
           + +NL++ EL    F +  E +Q ++T   R IL+ W+  + E ++L      ++V ++D
Sbjct: 23  VLNNLKLRELLLPKFTSLWE-IQTEVTVDNRTILLTWMHLLCESFELDKSVFPLSVSILD 81

Query: 283 WFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLK 342
            +LC+    ++ LQ +G  C+LI SK   +      +  +++ + ++  E++  E  +L+
Sbjct: 82  RYLCKKQGTKKTLQKIGAACVLIGSKIRTVKPMTVSKLTYLSCDCFTNLELINQEKDILE 141

Query: 343 CLGF 346
            L +
Sbjct: 142 ALKW 145


>pdb|1BU2|A Chain A, X-Ray Structure Of A Viral Cyclin From Herpesvirus Saimiri
          Length = 229

 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/124 (24%), Positives = 66/124 (53%), Gaps = 1/124 (0%)

Query: 223 IYSNLQVAELNRRPFPNFMETVQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTVYLID 282
           + +NL++ EL    F +  E +Q ++T   R IL+ W+  + E ++L      ++V ++D
Sbjct: 2   VLNNLKLRELLLPKFTSLWE-IQTEVTVDNRTILLTWMHLLCESFELDKSVFPLSVSILD 60

Query: 283 WFLCQNYIERQRLQLLGITCMLIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLK 342
            +LC+    ++ LQ +G  C+LI SK   +      +  +++ + ++  E++  E  +L+
Sbjct: 61  RYLCKKQGTKKTLQKIGAACVLIGSKIRTVKPMTVSKLTYLSCDCFTNLELINQEKDILE 120

Query: 343 CLGF 346
            L +
Sbjct: 121 ALKW 124


>pdb|1F5Q|B Chain B, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
           Complexed To Human Cyclin Dependent Kinase 2
 pdb|1F5Q|D Chain D, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
           Complexed To Human Cyclin Dependent Kinase 2
          Length = 252

 Score = 29.3 bits (64), Expect = 3.7,   Method: Compositional matrix adjust.
 Identities = 20/103 (19%), Positives = 43/103 (41%)

Query: 244 VQRDITQAMRGILVDWLVEVSEEYKLVPDTLYMTVYLIDWFLCQNYIERQRLQLLGITCM 303
           V +  T   R +L  W+  V ++ +   +   + V L+D       I+R+  Q      +
Sbjct: 40  VDQHFTSQYRKVLTTWMFCVCKDLRQDNNVFPLAVALLDELFLSTRIDRENYQSTAAVAL 99

Query: 304 LIASKYEEICAPRAEEFCFITDNTYSREEVLKMESQVLKCLGF 346
            IA K       +A +  ++     + +++L +E + L  L +
Sbjct: 100 HIAGKVRAYMPIKATQLAYLCGGATTADKLLTLEVKSLDTLSW 142


  Database: pdbaa
    Posted date:  Mar 3, 2013 10:34 PM
  Number of letters in database: 14,973,337
  Number of sequences in database:  62,578
  
Lambda     K      H
   0.318    0.130    0.378 

Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,509,650
Number of Sequences: 62578
Number of extensions: 358362
Number of successful extensions: 868
Number of sequences better than 100.0: 33
Number of HSP's better than 100.0 without gapping: 30
Number of HSP's successfully gapped in prelim test: 3
Number of HSP's that attempted gapping in prelim test: 837
Number of HSP's gapped (non-prelim): 33
length of query: 361
length of database: 14,973,337
effective HSP length: 100
effective length of query: 261
effective length of database: 8,715,537
effective search space: 2274755157
effective search space used: 2274755157
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)